Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Non-Alcoholic Steatohepatitis (NASH) Market by Drug Type (Vitamin E and Pioglitazone, Ocaliva, Elafibranor, Selonsertib, Cenicriviroc, and Others), Disease Cause (Hypertension, Heart Disease, High Blood Lipid, Type 2 Diabetes, Obesity), Sales Channel (Hos
... Retail Pharmacy), End User (Hospitals, Clinics, Homecare Settings), and Region 2023-2028 Market Overview: The global non-alcoholic steatohepatitis (NASH) market size reached US$ 1.21 Billion in 2022. Looking forward, IMARC Group expects the market to reach ... Read More
-
Dementia Drugs Market by Indication (Lewy Body Dementia, Parkinson’s Disease Dementia, Alzheimer’s Disease, Vascular Dementia, and Others), Drug Class (Cholinesterase Inhibitors, NMDA Antagonists and its Combination Drugs), Distribution Channel (Retail Ph
... and Region 2023-2028 Market Overview: The global dementia drugs market reached US$ 16.95 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 27.7 Billion by 2028, exhibiting a growth rate (CAGR) ... Read More
-
Anti-Obesity Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 4.0 Billion by 2028, exhibiting a growth rate (CAGR) of 11.7% during 2023-2028. Anti-obesity drugs are intended to reduce or control weight and generally medically prescribed only in cases of morbid obesity. They ... Read More
-
Global Migraine Drugs Market - 2023-2030
... The migraine drugs market is expected to exhibit a CAGR of 12.1% during the forecast period (2023-2030), owing to the increase in the preponderance of migraine globally and the increase in awareness regarding migraine and ... Read More
-
Global Systemic Lupus Erythematosus Market - 2023-2030
... by 2030. The systemic lupus erythematosus market is expected to exhibit a CAGR of 7.3% during the forecast period (2023-2030). Systemic lupus erythematosus (SLE) is a chronic autoimmune condition that can harm the skin, joints, ... Read More
-
Explainable AI Market Size, Share & Trends Analysis Report By Component, By Deployment, By Application (Fraud & Anomaly Detection, Drug Discovery & Diagnostics, Predictive Maintenance), By End-use, By Region, And Segment Forecast, 2023 - 2030
... by Grand View Research, Inc. Explainable AI refers to the development of artificial intelligence (AI) systems that can provide understandable and transparent explanations for their decision-making processes. While AI models have achieved remarkable performance in ... Read More
-
Next Generation Antibody Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type
... 2022 and its CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028. For geography segment, regional supply, demand, major players, price ... Read More
-
Global Chronic Disease Management Therapeutics and Device Technologies Market Size study & Forecast, by Disease (Cardiovascular diseases (CVD), Diabetes, Cancer, Chronic respiratory diseases, Chronic kidney diseases, Neurological disorders, Others (such as autoimmune diseases, gastrointestinal disorders, and many)) by Therapy (Medications, Rehabilitation therapy, Behavioral therapy, Others (such as gene therapy, stem cell therapy, and many)), by Device (Blood glucose monitoring devices, Blood pressure monitors, Cardiac monitors, Respiratory therapy devices, Kidney dialysis machines, Neurostimulation devices, Others (such as insulin pumps, continuous glucose monitoring devices, and many)) and Regional Analysis, 2023-2030
... and many)) by Therapy (Medications, Rehabilitation therapy, Behavioral therapy, Others (such as gene therapy, stem cell therapy, and many)), by Device (Blood glucose monitoring devices, Blood pressure monitors, Cardiac monitors, Respiratory therapy devices, Kidney dialysis ... Read More
-
Global Acute Myeloid Leukemia Market Size Study & Forecast, By Chemotherapy (Cytarabine, Anthracycline Drugs, Alkylating Agents, Anti-metabolites, Tyrosine Kinase Inhibitors, Hormonal Therapy, Other Chemotherapies), and Regional Analysis, 2023-2030
... at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Acute Myeloid Leukemia (AML) is a form of blood ... Read More
-
Psoriatic Arthritis (PsA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... 6 million prevalent cases of PsA in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast. There are 14 leading marketed drugs for the treatment of PsA, Janssen is the key player in the ... Read More
-
Global Periodontal Therapeutics Market - 2023-2030
... therapeutics market is expected to exhibit a CAGR of 9.2% during the forecast period (2023-2030). Adjuvant therapies following the use of antibiotics will support the trend in this market. The non-surgical treatment procedures for gum ... Read More
-
Global Cerebral Palsy Treatment Market - 2023-2030
... The global cerebral palsy treatment market is expected to exhibit a CAGR of 3.7% during the forecast period (2023-2030). The key players are adopting strategies such as partnerships, mergers, acquisitions, and regional expansion to stand ... Read More
-
Quantum Computing in Healthcare Market by Component (Hardware, Software), Deployment (0n-premises, Cloud-based), Technology (Superconducting qubits, Trapped ions), Application (Drug discovery, Genomics), End User, and Region - Global Forecast to 2028
... healthcare market is projected to reach USD 503 million by 2028 from USD 85 million in 2023, at a high CAGR of 42.5% during the forecast period. The technological advancements in quantum computing supporting various ... Read More
-
Global Scleroderma Market - 2023-2030
... exhibit a CAGR of 6.2% during the forecast period (2023-2030). The key market players are adopting various strategies such as product approvals, acquisitions, partnerships, and new launches to increase product reach and strengthen their product ... Read More
-
Global Depression Drugs Market Research Report 2023(Status and Outlook)
... at any age may suffer from depression. Depression affects the brain, so drugs that work in the brain may offer hope. Common antidepressants may help ease your symptoms, but there are many other options as ... Read More
-
Global Multiple Sclerosis Drugs Market Research Report 2023(Status and Outlook)
... This damage disrupts the ability of parts of the nervous system to communicate, resulting in a range of signs and symptoms, including physical, mental, and sometimes psychiatric problems. The Global Multiple Sclerosis Drugs Market Size ... Read More
-
Global Anti Malarial Drug Market Research Report 2023(Status and Outlook)
BSR000150927 Read More
-
Global Benign Prostatic Hyperplasia BPH Drugs Market Research Report 2023(Status and Outlook)
... in puberty, when the prostate doubles in size. The second phase of growth starts around age 25 and goes on for most of the rest of a man's life. BPH most often occurs during this ... Read More
-
Global Microbiome Therapeutics Market Research Report 2023(Status and Outlook)
... microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. ... Read More
-
Global Benign Prostatic Hyperplasia BPH Drugs Market Research Report 2023(Status and Outlook)
... in puberty, when the prostate doubles in size. The second phase of growth starts around age 25 and goes on for most of the rest of a man's life. BPH most often occurs during this ... Read More
-
Global Artificial Intelligence-driven Drug Development Market Growth (Status and Outlook) 2023-2029
... it is expected to grow at a CAGR of 31.8% from 2023 to 2029. United States market for Artificial Intelligence-driven Drug Development is estimated to increase from US$ million in 2022 to US$ million by ... Read More
-
Global Invasive Fungal Infections Market: Analysis By Molecule Class (Azoles, Echinocandins, Allylamines/Pyrimidines, Polyenes and Others), By Infection Type (Candidiasis, Aspergillosis, Cryptococcus, and Other), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028
... to 2028 Invasive fungal infections (IFIs) are serious and potentially life-threatening infections caused by fungi that invade deep tissues, organs, or the bloodstream of the human body. These infections can occur in individuals with weakened ... Read More
-
Global Peptide Therapeutics Market Report and Forecast 2023-2031
... the globe. The market size is anticipated to grow at a CAGR of 7.6% during the forecast period of 2023-2031 to achieve a value of USD 69.9 billion by 2031. Peptide Therapeutics: Introduction Peptide therapeutics ... Read More
-
Global Artificial Intelligence in Drug Discovery and Development Market Growth (Status and Outlook) 2023-2029
... to US$ 9235.1 million in 2029; it is expected to grow at a CAGR of 31.8% from 2023 to 2029. United States market for Artificial Intelligence in Drug Discovery and Development is estimated to increase ... Read More
-
Global Central Nervous System Biomarkers Market Size study & Forecast, by Type (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers, Others) by Application (Drug Discovery and Development, Personalized Medicine, Other Applications), by End User (Diagnostic Labs, Clinics/Hospitals, Research Centers) and Regional Analysis, 2022-2029
... Research Centers) and Regional Analysis, 2022-2029 Global Central Nervous System Biomarkers Market is valued approximately at USD 4.19 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 9.00% ... Read More
Research Assistance
